← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.

Marissa Spino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30397180